Trump Announces Next HHS Nominee, Dems Scrutinize His Former Employment

HE'S THE CURE President Donald Trump has selected drug industry executive Alex Azar to replace former Health and Human Services Secretary Tom Price. Here Director of French research laboratory the Pasteur Institute Alice Dautry smiles next to US D

HE'S THE CURE President Donald Trump has selected drug industry executive Alex Azar to replace former Health and Human Services Secretary Tom Price. Here Director of French research laboratory the Pasteur Institute Alice Dautry smiles next to US D

Former U.S. Department of Health and Human Services Deputy Secretary Alex Azar was nominated by President Donald Trump Monday to lead the department as secretary, a post left vacant by the departure of Tom Price in September.

"He will be a star for better healthcare and lower drug prices", Trump said in a tweet announcing the nomination.

Democrats like Wyden, however, expect Azar to "faithfully implement" the Affordable Care Act.

Azar, who ran Indianapolis-based Lilly's USA operations until earlier this year, has been an advocate for more state flexibility under Obamacare.

As secretary, Azar would have broad authority over many aspects of the program.

There are signs that the law is gaining popular support despite the repeal efforts.

The firm represents a sophisticated client base of Fortune 100 life sciences, health care services companies, and providers as well as innovative, venture and private equity backed companies in diagnostics, digital health, health information technology and health care services. Early enrollment in Obamacare plans earlier this month was also up considerably compared to a year ago.

The nomination comes two months after former HHS Secretary Tom Price resigned due to a private plane scandal.

If approved, Azar will be deeply involved in regulating the industry he has worked for over the last decade.

HE'S THE CURE: President Donald Trump has selected drug industry executive Alex Azar to replace former Health and Human Services Secretary Tom Price. However he's taken no concrete action yet to do so. "During Azar's tenure as president and vice president, Eli Lilly raised the price of Humalog by 345 percent from $2,657.88 per year to $9,172.80 per year".

Azar previously worked at the department as deputy secretary under President George W. Bush before joining the pharmaceutical industry.

Noticias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.